South Dartmouth (MA): MDText.com, Inc
Studies have shown they are equally effective for weight loss and managing blood sugar levels in diabetes as injections
Back Zander, M, Madsbad, S, Madsen, JL, Holst, JJ (9 March 2002) 'Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study', The Lancet , 359/9309, 824-30
Its hard to think, if its 2030, and we have many of these medicines that weve proven the benefits for chronic diseases and the government said its worth it after this two-year pilot theyre doing its hard to think of too many employers who would say, Thats not for me, Ricks told me
Half of GLP-1 patients discontinue treatment within a year , and a significant portion of the population refuses to be anywhere near a needle
The most commonly observed side effects in the trial were nausea, diarrhea, and vomiting